February 4, 2023
You are here:  Home  >  Health Care & Life Science  >  Current Article

U.K. crackdown sinks Sientra stock price


Just days after Sientra might have been celebrating raising $66 million in capital, the breast implant maker finds itself in the cross hairs of health regulators in the United Kingdom and class-action lawyers in the U.S. Sientra’s stock price nosedived more than 52 percent on Sept. 24, just one day after the Goleta-based company completed…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.